BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35377778)

  • 1. Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry.
    Hakimi K; Carbonara U; Djaladat H; Mehrazin R; Eun D; Reese A; Gonzalgo ML; Margulis V; Uzzo RG; Porter J; Sundaram CP; Abdollah F; Mottrie A; Tellini R; Ferro M; Walia A; Saidian A; Soliman S; Yuan J; Veccia A; Ghoreifi A; Cacciamani G; Bhattu AS; Meng X; Farrow JM; Jamil M; Minervini A; Rha KH; Wu Z; Simone G; Autorino R; Derweesh IH
    J Urol; 2022 Aug; 208(2):268-276. PubMed ID: 35377778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
    Hsieh HC; Wang CL; Chen CS; Yang CK; Li JR; Wang SS; Cheng CL; Lin CY; Chiu KY
    PLoS One; 2022; 17(12):e0278038. PubMed ID: 36454803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
    J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial Carcinoma.
    Ikeda M; Matsumoto K; Sakaguchi K; Ishii D; Tabata KI; Kurosawa K; Urakami S; Okaneya T; Iwamura M
    Clin Genitourin Cancer; 2017 Oct; 15(5):556-562. PubMed ID: 28501481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.
    Dominguez-Escrig JL; Peyronnet B; Seisen T; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Gontero P; Lam T; MacLennan S; Mostafid H; Palou J; van Rhijn BWG; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol Focus; 2019 Mar; 5(2):224-241. PubMed ID: 29158169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population-based, propensity score-matched study.
    Dong F; Xu T; Wang X; Shen Y; Zhang X; Chen S; Zhong S; Zhang M; Ding Q
    Int J Clin Oncol; 2019 Mar; 24(3):296-305. PubMed ID: 30334174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcomes of laparoscopic radical nephroureterectomy in conjunction with template-based lymph node dissection: An extended follow-up study.
    Matsumoto R; Abe T; Takada N; Minami K; Harabayashi T; Nagamori S; Hatanaka KC; Yamashiro K; Kikuchi H; Osawa T; Maruyama S; Shinohara N
    Urol Oncol; 2020 Dec; 38(12):933.e13-933.e18. PubMed ID: 32534960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.
    Zhai TS; Jin L; Zhou Z; Liu X; Liu H; Chen W; Lu JY; Yao XD; Feng LM; Ye L
    BMC Cancer; 2019 Dec; 19(1):1207. PubMed ID: 31830927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.
    Seisen T; Shariat SF; Cussenot O; Peyronnet B; Renard-Penna R; Colin P; Rouprêt M
    World J Urol; 2017 Apr; 35(4):535-548. PubMed ID: 26809456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic assessments in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy and systematic regional lymph node dissection.
    Sato R; Watanabe K; Matsushita Y; Watanabe H; Motoyama D; Ito T; Sugiyama T; Otsuka A; Miyake H
    Urologia; 2022 Aug; 89(3):354-357. PubMed ID: 34325582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma.
    Raza SJ; Miller C; May A; Davaro F; Siddiqui SA; Hamilton Z
    Can J Urol; 2019 Aug; 26(4):9852-9858. PubMed ID: 31469641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023.
    Yanagisawa T; Kawada T; von Deimling M; Laukhtina E; Kimura T; Shariat SF
    Curr Opin Urol; 2023 Jul; 33(4):258-268. PubMed ID: 37014743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
    Burger M; Shariat SF; Fritsche HM; Martinez-Salamanca JI; Matsumoto K; Chromecki TF; Ficarra V; Kassouf W; Seitz C; Pycha A; Tritschler S; Walton TJ; Novara G
    World J Urol; 2011 Aug; 29(4):465-72. PubMed ID: 21630120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic Nephroureterectomy
    Kenigsberg AP; Smith W; Meng X; Ghandour R; Rapoport L; Bagrodia A; Lotan Y; Woldu SL; Margulis V
    J Endourol; 2021 Mar; 35(3):312-318. PubMed ID: 33081512
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection.
    Abe T; Kondo T; Harabayashi T; Takada N; Matsumoto R; Osawa T; Minami K; Nagamori S; Maruyama S; Murai S; Tanabe K; Shinohara N
    Jpn J Clin Oncol; 2018 Nov; 48(11):1001-1011. PubMed ID: 30272169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes.
    Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K
    Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of lymph node dissection in cN+ patients in the treatment of upper tract urothelial carcinoma: Analysis of NCDB registry.
    Piontkowski AJ; Corsi N; Morisetty S; Majdalany S; Rakic I; Li P; Arora S; Jamil M; Rogers C; Autorino R; Abdollah F
    Urol Oncol; 2022 Sep; 40(9):409.e9-409.e17. PubMed ID: 35623996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study.
    Lee HY; Chang CH; Huang CP; Yu CC; Lo CW; Chung SD; Wu WC; Chen IA; Lin JT; Jiang YH; Lee YK; Hsueh TY; Chiu AW; Chen YT; Lin CM; Tsai YC; Chen WC; Chiang BJ; Huang HC; Chen CH; Huang CY; Wu CC; Lin WY; Tseng JS; Ke HL; Yeh HC
    Front Oncol; 2022; 12():791620. PubMed ID: 35574295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.